Search

Rare Disease Advisor
Rare Disease Advisor @RareDisease_Adv ·
Inhaled #Treprostinil is associated with smaller decline in forced vital capacity and fewer clinical worsening events compared with placebo in patients with #IPF. Results from a multinational phase 3 clinical trial called TETON-2 (#NCT05255991) Read more: bit.ly/485v0HC
TETON-2 Phase 3 Trial Shows Benefits of Inhaled Treprostinil in IPF

A recent clinical trial shows inhaled treprostinil is associated with a smaller decline in forced vital capacity and fewer clinical worsening events compared with the placebo in IPF.

From rarediseaseadvisor.com
40
anatabeira #Presente
anatabeira #Presente @_anatabeira ·
Me horrorizan las palabras del presidente argentino después de ganar él juicio en USA por nacionalizacion de #IPF ! En lugar de festejar arremete contra @Kicillofok ! La derecha siempre igual !! En 🇺🇾 deseaban qué #Tabare perdiera juicio con tabacaleras !!!
22
Healio Pulmonology
Healio Pulmonology @HealioPulm ·
🗨️"If TETON-2 results are replicated, patients with #IPF may soon have access to another treatment option that could be used as monotherapy or in combination,"@ahajaricase, MD, FCCP,@PFFORG &@PiedmontHealth, said in a Healio Perspective.vist.ly/4wgen8
Inhaled treprostinil lowers FVC decline in IPF at 52 weeks

With receipt of inhaled treprostinil for 52 weeks, adults with idiopathic pulmonary fibrosis had less FVC decline compared with those receiving placebo, according to results published in The New...

From healio.com
28
cristina lust
cristina lust @CristinaLust ·
Quien puede creer las palabras de este mamarracho cuando todas sus politicas son en contra de nuestro pais y su sumision a EEUU e Israel a la vista hasta con posibilidades de l llevarnos a una guerra en base a su alineamiento personal. Rata!! 😡😡��😡 #IPF #MileiEsUnaEstafa
8
ModernMedics
ModernMedics @ModernMediks ·
💡 Your IPF patient coughs 1,500× a day. You have zero to offer them. Until now. CORAL RCT: Nalbuphine ER cut cough 60% vs placebo. First drug to ever work. Phase 3 launching now. ❓ Do you treat IPF cough? Yes/No 👇#Pulmonology #IPF #InternalMedicine #MedTwitter nWN
2
552
株式会社ケーエムケー【公式】
株式会社ケーエムケー【公式】 @kmk_1970 ·
今年はIPFに出るぞ～！ってことで、プロジェクトが立ち上がりました🙌 「何か面白いもの作ろうよ」 「KMKのイメージキャラクターなんてどうですか？」 「お、いいねぇ～！」 「KMKってどんなイメージですか？」 「・・・・・」 なかなか先には進みません💦 今日も一日お疲れ様でした😅 #IPF #展示会 #企業公式がお疲れ様を言
52
GRI Bio, Inc.
GRI Bio, Inc. @GRI_BIO ·
Dr. Philip Molyneaux discussed GRI Bio’s Phase 2a clinical data in idiopathic pulmonary fibrosis, highlighting the study’s successful endpoints and how the observed safety profile compares with currently available therapies. Learn more here: bit.ly/47pCeWX $GRI #IPF
102
Healio Pulmonology
Healio Pulmonology @HealioPulm ·
Published in @NEJM: With receipt of inhaled #treprostinil for 52 weeks, adults with idiopathic pulmonary fibrosis (#IPF) had less #FVC decline compared with those receiving placebo. ➕Amy Hajari Case, MD, FCCP, @PFFORG, shares her Perspective. vist.ly/4w3f4
Inhaled treprostinil lowers FVC decline in IPF at 52 weeks

With receipt of inhaled treprostinil for 52 weeks, adults with idiopathic pulmonary fibrosis had less FVC decline compared with those receiving placebo, according to results published in The New...

From healio.com
65
@investigando
@investigando @rocatanho ·
En pacientes con tos crónica asociada a la fibrosis pulmonar idiopática, nalbufina en liberación extendida reduce la frecuencia objetiva de tos y la reportada por el paciente a las 6 sem #nalbuphineER #cough #IPF jamanetwork.com/journals/jama/…
Oral Nalbuphine in Idiopathic Pulmonary Fibrosis–Associated Cough

This randomized clinical trial examines the safety and efficacy of oral nalbuphine in patients with chronic cough caused by idiopathic pulmonary fibrosis.

From jamanetwork.com
4